About Xera Med
We are Plasma Med Research, now doing business as “Xera Med” which is derived from the Hebrew word “Zera” meaning “seed,” as we launch outside of simply blood and plasma based clinical studies take on Phase 0, II-IV drug and diagnostics trials. Ultimately, we serve as the necessary starting point — the seed — required for researchers to cultivate better treatments and more accurate diagnostics.
Most of our clinical study successes have been in women’s health. Consequently, our top study indications include: autoimmune diseases that predominantly affect women (i.e. Lupus, Rheumatoid Arthritis, Multiple Sclerosis, Thyroid), infertility issues, general obstetrics, Zika in pregnancy, preeclampsia, endometriosis, women’s sexual wellness, adult & pediatric gynecology, and ovarian, cervical & breast cancer.
Other clinical studies we conduct include gastroenterology, hematology, oncology, dermatology, neurology, psychiatry, ophthalmology, cardiology, endocrinology and general pediatrics.
Our direct connection to patients from multiple indications, strong recruitment & retention arm, and vast physician network allows us to provide impressive enrollment timelines with utmost quality.